Key Words: acute coronary syndrome ◼ atrial fibrillation ◼ congenital heart defects ◼ heart diseases ◼ heart failure ◼ stroke Sources of Funding, see page 1897 BACKGROUND: Although lower-complexity cardiac malformations constitute the majority of adult congenital heart disease (ACHD), the long-term risks of adverse cardiovascular events and relationship with conventional risk factors in this population are poorly understood. We aimed to quantify the risk of adverse cardiovascular events associated with lower-complexity ACHD that is unmeasured by conventional risk factors.
F
or children born with congenital heart disease, surviving to adulthood is now the norm. With the adult congenital heart disease (ACHD) population exceeding the population of affected children, 1 the burden of morbidity and mortality has shifted toward acquired diseases of adulthood. Populationbased and institutional ACHD registries demonstrate a high prevalence of coronary artery disease (CAD), [2] [3] [4] stroke, 5, 6 heart failure (HF), 7, 8 arrhythmia, 9, 10 and associated other cardiometabolic conditions [11] [12] [13] in the ACHD population, specifically among those with more complex lesions.
Although adults with lesions of high complexity (eg, single ventricles) increasingly receive comprehensive cardiovascular care in ACHD clinics, those with simpler lesions (eg, isolated septal or valvular defects) have measurably less consistent participation in specialized clinics and research studies. 14, 15 Thus, the risk of cardiac complications in the latter population is not well understood. Furthermore, the contribution of traditional risk factors to acquired cardiovascular disease has been difficult to characterize owing to limitations in population-scale ascertainment of risk factors in regionally fragmented systems of care for this population.
Here, we assess the relationship between lowercomplexity ACHD and cardiovascular disease risk using the UK Biobank (UKB), a large, prospective, populationbased cohort of >500 000 individuals with long-term follow-up. Specifically, we characterize the burden of cardiovascular risk factors and disease incidence in a real-world ACHD population composed primarily of lower-complexity cardiac malformations and quantify the risk for adverse cardiovascular events associated with ACHD that is unaccounted for by traditional cardiovascular risk factors.
METHODS
The data for this study are publicly available to registered investigators of the UKB, and the analytical methods are made available online by the authors at https://github.com/ priestlab/Circulation_2019_Saha.
Study Population
The study cohort was derived from the UKB, a large, prospective cohort study with comprehensive health data from >500 000 volunteer participants in the United Kingdom who were 37 to 73 years of age at recruitment in 2006 to 2010. The cohort has previously been described in detail. 16, 17 Studies using the UKB are exempt from Institutional Review Board approval because the data are deidentified and publicly available.
Classification of Adults With Congenital Heart Disease
Congenital heart disease was defined as any structural cardiac abnormality, inclusive of bicuspid aortic valve (AoV), present in the heart or adjoining great vessels from birth in the absence of syndromic illness (ie, syndromes characterized by extracardiac or neurocognitive manifestations in addition to cardiac malformations). A multistep classification algorithm (Figure 1 and Tables I-IV and Methods in the online-only Data Supplement) was developed to ascertain 2102 individuals with nonsyndromic ACHD and 497 983 comparison individuals without ACHD using hospital encounter statistics and selfreported medical history in the UKB.
Individuals with ACHD were further organized into mutually exclusive subgroups based on lesion ( Figure 1 and Table  V Figure I in the online-only Data Supplement). Complex defects (n=96), adapted in part from the definition of severe congenital heart disease by Marelli and colleagues, 18 represent lesions with a high likelihood of cyanosis and are made up of single ventricles, transposition complex, truncus arteriosus, tetralogy
Clinical Perspective
What Is New?
• This study quantifies the risk of cardiovascular morbidity directly attributable to lower-complexity congenital heart disease.
• We identified 2006 individuals with lower-complexity congenital heart disease in the UK Biobank, a large, prospective, population-based cohort of >500 000 individuals between 37 and 73 years of age with uniformly collected health information.
• Individuals with congenital heart disease had a higher burden of cardiovascular risk factors and incidence of adverse cardiovascular events compared with the general population.
• After adjustment for conventional cardiovascular risk factors, the risk of adverse cardiovascular events remained 2 to 13 times higher in individuals with congenital heart disease.
What Are the Clinical Implications?
• Adults with mild to moderate congenital heart disease represent a large population of individuals previously considered to be at low risk for cardiovascular morbidity without need for long-term subspecialized cardiovascular care.
• This study demonstrates that adults with lowercomplexity congenital heart disease are at significant risk of acquiring cardiovascular morbidities relative to the general population, highlighting the need for long-term surveillance and further research on prevention and risk mechanisms of acquired cardiovascular disease in this population.
Circulation. ORIGINAL RESEARCH ARTICLE of Fallot, atrioventricular canal defect, and total anomalous pulmonary venous return. All remaining lesions, the majority being left-to-right shunt defects, were categorized as noncomplex defects (n=924). Only the isolated AoV defects and noncomplex defects subgroups, representing mild to moderate ACHD, were considered for analysis in this study.
Outcome Phenotype Definitions
Cardiovascular outcomes were defined with the use of International Classification of Diseases, Ninth Revision, International Classification of Diseases, 10th Revision, and Operating Procedure Codes-4 codes from the hospital encounter statistics and death registries, as well as selfreported noncancer illnesses and operations. Definitions were adapted in part from previously described methods (Methods in the online-only Data Supplement). The primary end points for survival analysis were first occurrence of fatal or nonfatal acute coronary syndrome (ACS), ischemic stroke, HF, and atrial fibrillation (AF). In secondary and sensitivity analyses, a combined end point of major adverse cardiovascular events (MACEs), defined as first occurrence of any of the primary end points, was used. Owing to the availability of hospital admissions data predating the enrollment period, the followup period for each individual in this study spanned from 10 years before enrollment in the UKB until the occurrence of a primary end point, death, or censorship from UKB. This allowed a maximum of 22 years of follow-up. Continuous covariates used in fully adjusted multivariable Cox regression analyses were age, Townsend deprivation index (a validated measure of socioeconomic status in the United Kingdom), 19 body mass index, systolic blood pressure, and diastolic blood pressure. Categorical covariates used in Cox regression were sex, ethnicity (white, nonwhite), smoking status (current, former, never), alcohol consumption (daily, weekly, seldom), physical activity (low versus high, with low defined as not satisfying the World Health Organization recommendation of at least 3 d/wk of vigorous-intensity activity or 5 d/wk of moderate-intensity exercise), family history of cardiovascular disease, history of hypertension or use of antihypertensive medications, history of hyperlipidemia diagnosis or use of statins, and history of diabetes mellitus diagnosis or use of insulin (Methods and Table VI in the online-only Data Supplement). Covariates were measured at the time of enrollment and considered to be stable proxy measures for the span of the follow-up period (Methods and Table VII in the online-only Data Supplement).
Statistical Analysis
Statistical analyses were performed with the survival and survminer statistical packages in R version 3.4.3. Sociodemographic, lifestyle, and cardiometabolic covariates were compared across groups by use of χ 2 tests for categorical variables and Wilcoxon rank-sum test for continuous variables (assuming nonnormal distributions).
Cumulative incidence curves were generated for each of the primary end points. A multistate model 20 was used to take into account the competing risk of death and potential mediation effects between the primary end points. Multivariable Cox proportional hazards regression was then used to estimate hazard ratios (HRs) and 95% CIs after adjustment for the continuous and categorical covariates mentioned previously. Adherence of survival analyses to the underlying proportional hazards assumption was assessed with the Schoenfeld residuals test.
Individuals were then stratified into 3 categories of cardiovascular risk based on the number present of 8 classic cardiovascular risk factors (male sex, current/former smoking status, obesity [ie, body mass index >30 kg/m 2 ], low physical activity, family history of cardiovascular disease, diagnosis of/ treatment for hypertension, diagnosis of/treatment for hypercholesterolemia, diagnosis of/treatment for diabetes mellitus). Low (≤2), intermediate (3) (4) , and high (≥5) numbers of cardiovascular risk factors were equivalent to risk tertiles. Direct standardization was used to estimate age-adjusted incidence 
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rates for MACEs at each level of cardiovascular risk over the 22-year follow-up period. Cox proportional hazards regression was used to estimate HRs for MACEs associated with ACHD at each stratum of cardiovascular risk, adjusted for age, ethnicity, and Townsend deprivation index.
Sensitivity Analyses
Given the known risk of acquiring cardiac morbidity acutely in the perioperative setting, a sensitivity analysis was performed on the multistate Cox regression models for each primary end point in which individuals who had undergone cardiac surgery within 1 year before the event of interest were excluded from analysis (Table VIII in the online-only Data Supplement). Sensitivity analyses were undertaken to assess for potential misclassification of ACHD cases resulting from inference of ACHD using nonspecific diagnostic codes (Tables IX-XII in the online-only Data Supplement). In sensitivity analysis A (Table IX in the online-only Data Supplement), HRs for the isolated AoV defects group were estimated with both inclusion and exclusion of diagnostic codes specific for congenital aortic insufficiency or stenosis to assess for the effect of inferred cases on the estimates. In sensitivity analysis B (Table X in the online-only Data Supplement), the isolated AoV defects group was restricted to include inferred cases who were ascertained to have a valve defect using an earlier diagnostic age cutoff (aortic stenosis/insufficiency diagnosed at <50 years of age or AoV replacement at <55 years of age), thereby increasing the likelihood that the cause of valvular disease was a congenital malformation, not acquired calcific valvular disease ( Figure  I in the online-only Data Supplement). In sensitivity analysis C (Table XI in the online-only Data Supplement), individuals who had undergone AoV replacement procedures were excluded from the cohort to assess for selection bias because AoV replacement was a qualifying inclusion criterion for inference of isolated AoV defects. In sensitivity analysis D (Table  XII in the online-only Data Supplement), individuals who had an unspecified noncomplex defect (ie, heart surgery before 18 years of age or nonspecific diagnostic code for congenital heart disease) were excluded from analysis to assess for misclassification bias in the noncomplex defects subgroup.
RESULTS

Clinical Characteristics of the Study Population
We identified 2006 participants with mild to moderate ACHD, including 1082 participants with isolated AoV defects and 924 with noncomplex defects, and 497 983 individuals for comparison from the UKB. Cardiac magnetic resonance imaging data from 8 standard anatomic sequences were available for >20 000 individuals in the UKB; of 32 ACHD cases with available imaging data, 29 displayed clear confirmatory visual evidence of the assigned ACHD diagnosis, yielding a specificity of 91% for our ACHD classification algorithm ( Figure II in the online-only Data Supplement).
The sociodemographic, lifestyle, and cardiometabolic characteristics shown in Table 1 demonstrate a higher burden of cardiovascular risk factors among the ACHD cohort, including male predominance (59% versus 46%; P<0.001), slightly higher material deprivation (median Townsend Deprivation Index, −1.74 versus −2.14; P<0.001), and a higher proportion of current or former smokers (51% versus 46%; P<0.001). Several cardiometabolic risk factors were more prevalent in the exposed versus the unexposed individuals such as obesity (30% versus 24%; P<0.001), hypertension (69% versus 55%; P<0.001), hyperlipidemia (41% versus 19%; P<0.001), and diabetes mellitus (6.7% versus 3.8%; P<0.001). Both the isolated AoV and noncomplex defects subgroups followed the composite ACHD trends, with the exception of a similar proportion of men (46%) and a lower rate of current or former smoking (44%) in the noncomplex defects group relative to the comparison group. The isolated AoV defects group generally displayed a higher frequency of risk factors than the noncomplex defects group. There were no significant differences between the ACHD subgroups and the comparison group in age at enrollment, ethnicity, alcohol consumption, physical activity, and family history of cardiovascular disease.
Unadjusted Cumulative Incidence of Cardiovascular Morbidity
Over a median of 20 years of follow-up centered on the time of enrollment in the UKB, the unadjusted incidence of all primary end points occurred at a higher rate for ACHD-exposed individuals than the comparison individuals without ACHD (Figure 2) . By the end of the follow-up period, 5% to 12% of the ACHD cohort had incident ACS, ischemic stroke, or HF, and 20% had AF, compared with a <5% incidence of all end points for the non-ACHD population in this cohort. After adjustment for only sociodemographic factors (age, sex, ethnicity, and Townsend deprivation), the noncomplex ACHD subgroup demonstrated a significantly higher hazard of AF (P=0.00003) and ischemic stroke (P=0.007) than the isolated AoV defects subgroup. There was no significant difference in incidence rates of ACS and HF between the 2 ACHD subgroups.
Multivariable-Adjusted Multistate Cox Regression Analysis
After adjustment for common cardiovascular risk factors (ie, age, sex, ethnicity, Townsend Deprivation index, smoking status, alcohol consumption, physical activity, family history of cardiovascular disease, body mass index, hypertension, hyperlipidemia, diabetes mellitus), ACHD exposure continued to be strongly associated with the primary end points (Table 2) . Sensitivity analyses did not suggest that incident events were temporally related to perioperative risk ( ; P=0.95 for comparison).
Stratification by Level of Cardiovascular Risk
To compare the risk of MACEs in individuals with and without ACHD across different levels of cardiovascular risk, we stratified all participants by the number of cardiovascular risk factors present into low (0-2), intermediate (3) (4) , or high (5-8) risk tertiles. When stratified by cardiovascular risk level, the ACHD population continued to show dramatically greater age-adjusted absolute incidence of MACEs compared with the comparison group in the same cardiovascular risk stratum ( Figure 3A) . Compared across risk strata, the absolute incidence of MACE for the ACHD subgroups in the lowest stratum of cardiovascular risk (30 Figure 3B ). Ageadjusted incidence by risk strata for individual primary end points is shown in Figure III in the online-only Data Supplement. The disparate risk estimates for MACEs at different strata of cardiovascular risk suggested interaction between the cardiovascular risk factors and ACHD.
Tests for interaction between the ACHD subgroups and individual cardiovascular risk factors (Table XIII in the online-only Data Supplement) demonstrated that the presence of ACHD significantly modified the effects of sex, hypertension, and hyperlipidemia on the risk of MACEs (significant at P<0.003 after Bonferroni correction). Furthermore, the estimated β coefficients for the interaction terms between ACHD and the aforementioned risk factors were all <0, demonstrating that the effect of the risk factors was relatively smaller in the ACHD-exposed group than in the unexposed comparison group. These results imply that traditional cardiovascular risk factors may have a less pronounced, albeit still significant, role in conferring risk for MACEs in the ACHD versus non-ACHD population. Cumulative incidence of acute coronary syndrome, ischemic stroke, heart failure, and atrial fibrillation in adults with congenital heart disease compared with the general UK Biobank population. A through D, Unadjusted cumulative incidence of acute coronary syndrome, ischemic stroke, heart failure, and atrial fibrillation in individuals with isolated aortic valve (AoV) defects, with noncomplex defects, and without adult congenital heart disease (controls).
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DISCUSSION
In this population-based study of ACHD-associated risk of cardiovascular disease, we observed a substantial burden of adverse cardiovascular events in a cohort of older adults with simple to moderately complex ACHD. We discerned substantial residual risk for adverse cardiovascular events in the ACHD cohort that is disproportionate to the burden of known cardiovascular risk factors noted in this subgroup of the UKB. These findings provide further evidence for a cardiovascular disease risk profile unique to individuals with mild to moderate ACHD and highlight the need to extend preventive care practices beyond the management of conventional risk factors for this population.
The residual risk of adverse cardiovascular events after adjustment for conventional risk factors was considerably higher in individuals with ACHD compared with the general UKB population, ranging from a 2-fold increased risk of ACS to a 13-fold increased risk of HF. Our estimates are similar in magnitude to risk estimates derived from younger ACHD populations that were adjusted for only a small number of conventional cardiovascular risk factors. [21] [22] [23] [24] At a median enrollment age of 58 years, the ACHD cohort, particularly individuals with isolated AoV defects, in the UKB had a higher frequency of current or former smokers, obesity, hypertension, hyperlipidemia, and diabetes mellitus than the rest of the UKB. Other ACHD cohorts comprising younger individuals (median age, 28-29 years) were observed to have higher rates of obesity, hypertension, and diabetes mellitus, indicating that such risk factors may be present from early adulthood. 5, 22, 25 Despite an overall higher burden of cardiovascular risk factors in the ACHD cohort, we observed a significantly higher incidence of MACEs in the ACHD subgroups than the general UKB population when comparing individuals at similar levels of cardiovascular risk. Among those with ≤2 cardiovascular risk factors, there was a 29% age-adjusted incidence of MACE in the ACHD cohort compared with only a 3% incidence among the comparison group, suggesting that ACHDassociated risk mechanisms are key determinants of cardiovascular risk in the ACHD population regardless of conventional risk factors. As has been hypothesized, [24] [25] [26] ACHD-associated factors may even modify the effect of conventional risk factors as suggested by the variation in relative risk at different risk levels. Notably, because the ACHD population in this study represents mild to moderate lesions, valvular and septal defects being the most common subtypes, these findings further emphasize the critical importance of surveillance of this highly prevalent ACHD subgroup, which often lacks long-term clinical follow-up 26, 27 despite having higher risk of mortality and morbidity compared with the general population.
10,28,29 ACHD indicates adult congenital heart disease; ACS, acute coronary syndrome; AF, atrial fibrillation; AoV, aortic valve; HF, heart failure; and HR, hazard ratio.
*Adjusted for sociodemographic factors (age at enrollment, sex, ethnicity, and Townsend Deprivation Index). †Adjusted for sociodemographic factors as in unadjusted models plus cardiovascular risk factors (smoking status, alcohol consumption, physical activity, family history of cardiovascular disease, body mass index, systolic and diastolic blood pressures adjusted for use of antihypertensive medication, hyperlipidemia, diabetes mellitus).
‡Number at risk reflects total number of participants with nonmissing values for the event within the predetermined follow-up time.
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Although the long-term risks of HF and arrhythmia associated with ACHD are well described, 8, 30, 31 morbidity from ACS and stroke in the ACHD population is a more recently recognized phenomenon because of increasing life expectancy. 32, 33 In this study, the elevated risk of ACS and ischemic stroke associated with ACHD despite adjustment for atherosclerotic risk factors suggests a nonatherosclerotic cause of cardiovascular disease. The development of cardiovascular disease may be related to a number of other factors, including surgical interventions, 34 physiological stressors of early life, 35 intrinsic cellular dysfunction, and genetic predisposition. 30 Risk for ischemic stroke and AF has previously been associated with septal defects (with or without closure) and palliative shunt procedures, 4, 28, 36 suggesting a cardioembolic rather than atherosclerotic mechanism. Indeed, our study exhibits a greater risk of ischemic stroke and AF among those with noncomplex defects (composed primarily of septal defects) compared with those with isolated AoV defects, supporting the existing literature. In individuals with repaired coarctation of the aorta, predisposition for CAD has been associated with endothelial dysregulation, increased intima-media thickness, and an inflammatory cytokine profile, 37 all of which may be intrinsic to the congenital anomaly itself or a result of surgical intervention. Mechanisms of intraoperative inflammation resulting in vascular injury mediated by cytokines such as transforming growth factor-β1 have been proposed but require further investigation. 38 Although reports on the prevalence of CAD in adults with AoV malformations are variable, 39 bicuspid AoV has been associated with a higher incidence of CAD than expected for age 40 and with underlying vasculopathies that predispose to CAD. 41 Variation at the TEX41 locus discovered through genome-wide association study has recently been associated with both bicuspid AoV and CAD, 42 further underscoring the potential for a shared genetic basis of congenital heart malformations and acquired cardiovascular disease. Further investigation is necessary to delineate these potential mechanisms of cardiovascular disease unique to ACHD.
There are several strengths to this study. The data are derived from a large population-based cohort with comprehensive and uniformly collected data on all participants, regardless of diagnosis of congenital heart disease, thereby decreasing potential detection bias. In addition, the breadth of clinical data available in the UKB allowed us to define and adjust for a range of sociodemographic, behavioral, and cardiometabolic potential confounding variables that were uniformly ascertained in individuals with ACHD and those without ACHD alike. Although the availability of baseline characteristics is greater than in most registry-based studies, which often lack survey instruments, inclusion of covariates was restricted to cross-sectional data obtained at the time of enrollment (which occurred at different ages), thus potentially complicating interpretation. However, a sensitivity analysis assessing the potential bias introduced by time-static covariates showed no significant variation in results (Table VII in the onlineonly Data Supplement).
Our study shares limitations inherent to observational studies. As previously reported, the UKB is subject to a healthy volunteer bias 43 and includes individuals born during an earlier era of congenital heart disease. In the United Kingdom, the first complete repair for tetralogy of Fallot performed in an infant occurred in the early 1960s, and with the UKB cohort born between 1931 and 1971, the majority of UKB participants predate the widespread availability of palliative procedures for com- plex ACHD. Thus, survivorship bias is also present, as evidenced by the small number of participants with ACHD classified as complex who were excluded from analysis. Furthermore, diagnoses and outcomes of interest managed only in an outpatient setting will not be well captured within the UKB or similar population-based registries. 44 As a result, our classification algorithm is based primarily on hospital admission diagnoses, which lack the specificity, sensitivity, and phenotypic detail available in institutional or practice-based ACHD registries. 45 Although validation of our classification algorithm was limited by the inability to verify individual-level diagnoses with chart review, the sheer volume of control individuals for comparison dilutes any effects of falsenegative classifications of ACHD. Furthermore, whereas magnetic resonance imaging was available for only 2% of all patients with ACHD, visual inspection of available magnetic resonance imaging data yielded a diagnostic positive predictive value of at least 91% ( Figure II and Movies I and II in the online-only Data Supplement), providing a unique visual method of validation that is not possible in registry-based studies. Despite the limitations present, the classification algorithm ascertained a prevalence of ACHD of 4.2 per 1000 participants, which is reasonably within the range of previously published prevalence estimates of 2.17 to 6.12 per 1000 adults. 10, 46, 47 The potential for misclassification bias was most pronounced in the ascertainment of isolated AoV defects. Given the lack of a highly sensitive diagnostic code for congenital AoV malformations and the largely asymptomatic course in early life, the identification of these lesions is a challenge in any setting without imaging data. Although the majority of isolated AoV defects were inferred with non-imaging-derived diagnostic information, we were able to increase our confidence in the classification through multiple sensitivity analyses (Table IX -XII in the online-only Data Supplement that demonstrated minimal changes in any estimates for cardiovascular outcomes. The roughly 1:1 ratio of isolated AoV defects to all other ACHD lesions and the predominance of men (68.9%) are also consistent with prior studies estimating the birth prevalence and sex ratio of bicuspid AoVs. 48, 49 Although our classification algorithm does not allow the identification of asymptomatic AoV defects, the literature suggests that most individuals with bicuspid AoVs have acquired dysfunction by late adulthood.
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Conclusions
In this analysis of ≈500 000 British individuals from the UKB, we found a substantially higher burden of cardiovascular risk factors and disease incidence in individuals with lower-complexity ACHD than in the general population. Furthermore, we estimated significant residual risk of adverse cardiovascular events associated with ACHD after adjusting for conventional cardiovascular risk factors. These findings highlight the importance of establishing long-term follow-up in patients with simple to moderately complex ACHD and the need for further study of the mechanisms of cardiovascular disease specific to this rapidly growing population of high-risk adults.
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